In vitro and in vivo intracellular delivery of quantum dots by maurocalcine

Archive ouverte

Ram, Narendra | Texier-Nogues, Isabelle | Pernet-Gallay, Karine | Poillot, Cathy | Pirollet, Fabienne | Ronjat, Michel | Andrieux, Annie | Arnoult, Christophe | Daou, Jean | de Waard, Michel

Edité par CCSD -

International audience. Maurocalcine is a new member of the increasing family of cell penetrating peptides. We report for the first time that this peptide is able to deliver quantum dots inside a variety of cells, both in vitro and in vivo. In vivo, maurocalcine produces intracellular delivery of the nanoparticles without affecting the relative distribution of quantum dots within organs. The data stress out that maurocalcine can be used for intracellular delivery of functionalised nanoparticles in vivo.

Suggestions

Du même auteur

Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.

Archive ouverte | Ram, Narendra | CCSD

International audience. Maurocalcine is a 33-mer peptide initially isolated from the venom of a Tunisian scorpion. It has proved itself valuable as a pharmacological activator of the ryanodine receptor and has helpe...

Maurocalcine-derivatives as biotechnological tools for the penetration of cell-impermeable compounds. Maurocalcine-derivatives as biotechnological tools for the penetration of cell-impermeable compounds: Technological value of a scorpion toxin

Archive ouverte | Ram, Narendra | CCSD

Maurocalcine is a unique toxin in that its natural pharmacological target in vivo, the ryanodine receptor, is localized inside cells and not at the cell surface as commonly observed for most toxins. According to the membrane topol...

Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231.. : Maurocalcine as good doxorubicin delivery vector

Archive ouverte | Aroui, Sonia | CCSD

International audience. PURPOSE: The aim of this study is to overcome tumour cell resistance that generally develops after administration of commonly used anti-cancer drugs, such as doxorubicin. METHODS: Recently, c...

Chargement des enrichissements...